Most drug trials fail, and failure is expensive. This is a list of 13 failed clinical trials of drug candidates in 2018 that also touched off a variety of consequences that included termination of development programs, losses in the millions, layoffs, and more. Five of the 13 failed drug candidates were for Alzheimer’s treatments. (Genetic Engineering & Biotechnology News)